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The Australian National H
and Medical Research Co
(NHMRC) immunisation guid
recommend pre-exposure rabie
cination for:2
• “Expatriates and travellers wh
be spending prolonged periodObjectives:  To examine the circumstances of animal exposure in a case series 
of Australian travellers who required rabies postexposure prophylaxis, and to 
assess the appropriateness of current guidelines for rabies pre-exposure 
vaccination.
Design, participants and setting:  Prospective case series of 65 returned 
travellers who presented to four Australian travel medicine clinics between 
1 April 2009 and 31 July 2010 for rabies post-exposure prophylaxis.
Main outcome measures:  Demographic characteristics associated with risk 
of injury; countries where injuries occurred; circumstances of the injuries; and 
travellers’ experiences of obtaining postexposure prophylaxis overseas.
Results:  Animal bites and scratches occurred most commonly among travellers 
aged 20–29 years. Most injuries occurred in Bali, Indonesia (30 [46%]) and 
Thailand (21 [32%]), and the most common animals responsible for the injuries 
to the 65 travellers were monkeys (29 travellers [45%]) and dogs (27 [42%]). 
Thirty-nine of the travellers (60%) initiated contact with the animal. Forty 
travellers (62%) were able to commence rabies vaccination overseas, but 
only nine (14%) were able to obtain rabies immunoglobulin overseas.
Conclusions:  Most travellers had difficulty obtaining rabies postexposure 
prophylaxis overseas, resulting in significant delays in appropriate treatment. 
We recommend that current National Health and Medical Research Council 
guidelines for at-risk persons be broadened, and that the risk of rabies and 
the option of pre-exposure vaccination be discussed with all travellers to 
rabies-endemic areas.
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R ies poses a threat to over billion people worldwide,d causes an estimated
aths each year.1 The disease
is endemic in Asia, Africa, Europe
and the Americas, and is maintained
by a wide range of animals. The vast
majority of deaths occur in Asia and
Africa and, annually, more than 15
million people receive postexposure
prophylaxis (PEP) for rabies.1 Aus-
tralia is free of rabies, but Australian
bat lyssavirus causes a rabies-like
illness.2
Australians make 6.8 million short-
term international departures each
year, with over 3 million of these to
Asia.3 Many travellers are therefore
exposed to the risk of rabies. The
emergence of rabies in Bali, Indone-
sia, since 2008 has resulted in over 100
human deaths,4 and returned travel-
lers from Bali now account for a sig-
nificant proportion of those seeking
rabies PEP in Australia.5
Travellers can be protected from
rabies by either vaccination before
exposure, or PEP. The World Health
Organization (WHO) recommenda-
tions for PEP include prompt wound
cleaning, administration of rabies
immunoglobulin (RIG) into or
around the wound, followed by a
course of rabies vaccines.1 Ideally,
PEP should be commenced as soon
as possible after any potential expo-
sure to rabies. Although it is possible
for travellers to seek PEP overseas, it
can be difficult for them to obtain
treatment promptly, and RIG is often
unavailable.1 Vaccination against
rabies before exposure eliminates the
need for RIG, reduces the number of
vaccine doses after a potential expo-
sure, and reduces the urgency of
starting PEP.
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s (ie,
more than a month) in rabies-endemic
areas. (NB. This time interval, of more
than a month, is arbitrary, and rabies
has occurred in travellers following
shorter periods of travel)”, and
• “People working with mammals in
rabies-endemic areas”.
In this article, we pose the question:
Are the current Australian guidelines
for rabies pre-exposure vaccination
appropriate, given the common cir-
cumstances in which travellers are
exposed to animal bites? To examine
this question, we report a case series of
travellers who were bitten or scratched
by animals in rabies-endemic areas
and sought PEP on their return to
Australia. We describe the circum-
stances of their exposure and their
experience with obtaining PEP over-
seas, and we consider these findings in
the context of the current NHMRC
guidelines for rabies vaccination.
Methods
We collected data on travellers who
were bitten or scratched by animals in
rabies-endemic areas, and who pre-
sented to three travel medicine clinics
in Queensland (Brisbane, Gold Coast,
and Maroochydore) and one in West-
ern Australia (Perth) between 1 April
2009 and 31 July 2010. All returned
travellers who presented for PEP were
included, and the treating doctor used
a questionnaire to collect the data.
Data collection
The questionnaire used by doctors at
each clinic sought routine information
on:
• demographic characteristics of the
injured traveller;
• the geographical location where
the injury occurred;
• the nature of the injury;
• the type of activity the traveller
was engaged in when injury occurred,
and any initiation of animal contact;
• pre-exposure rabies vaccination;
and
• PEP obtained overseas and on
return to Australia.
Results
The 65 returned travellers (45 from
Queensland and 20 from Perth) who
presented for PEP during the 16-
month study period included 36
males (55%) and 29 females (45%).
The highest number of injuries was
seen in travellers aged 20–29 years.
Box 1 shows the age distribution of
travellers in our study compared with673MJA 195 (11/12) · 5/19 December 2011
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residents making short-term depar-
tures from Australia in 2010.6
Circumstances of animal exposure
Fifty-one travellers (78%) reported
bites ,  and  11 (17%) reported
scratches. The most common body
parts injured were the hand (includ-
ing thumb or fingers), followed by the
leg and the arm (Box 2).
Box 3 shows that the most common
destinations where travellers were
injured were Bali, Indonesia (30 travel-
lers [46%]), and Thailand (21 [32%]).
Currently, 9.6% of Australian short-
term resident departures are made to
Indonesia, and 6.4% to Thailand.3
Injuries in our series occurred with
equal frequency in urban (23 travellers
[35%]) and rural (22 [34%]) areas; 10
travellers (15%) were injured at an
animal park or zoo. Of the 30 travel-
lers injured in Bali, 18 (60%) were
bitten or scratched by monkeys, and
13 travellers (43%) were injured while
feeding or interacting with the ani-
mals at a “monkey forest” or “mon-
key temple”.
The animals most commonly
responsible for injuries were mon-
keys (29 travellers [45%]) and dogs
(27 [42%]),  but other species
included cats, an orangutan, and a
tiger. Thirty-nine of the travellers
(60%) initiated contact with the ani-
mal. This included patting, touching,
or picking up the animal (14 travel-
lers); feeding the animal (10); taking
photographs of or having photo-
graphs taken with the animal (5); and
reaching for or waving at the animal,
or shooing it away (5). Twenty-two
travellers (34%) were bitten without
initiating contact with animals, and
none were working with animals.
Travellers were injured a mean of
15.3 days after their departure from
Australia (range, 0–95 days), and 51
out of 58 (88%) were injured within 30
days. The timing of exposure was
unknown for the other seven travellers.
Pre-exposure rabies vaccination 
and postexposure prophylaxis
Only one traveller had received pre-
exposure rabies vaccination. Forty
travellers (62%) commenced PEP
while overseas, and only nine of these
(14%) were able to obtain RIG. Some
travellers received RIG after they
returned to Australia, and those who
presented more than 7 days from their
first rabies vaccine dose did not
receive RIG (as recommended by the
NHMRC).2 Overall, only 35 travellers
(54%) completed PEP as recom-
mended by the WHO and received
RIG and all doses of the vaccine; 29
travellers (45%) received vaccines
only (Box 4).
The 36 travellers who received RIG
were treated an average of 13.2 days
after the injury (range, 0–134 days),
and only four obtained RIG within 48
hours. Of the 61 travellers who
received the vaccine, the average
delay in starting the vaccination was
9.1 days, but 33 (54%) received the
first dose within 48 hours.
Discussion
In our case series, most injuries
occurred less than 30 days after arriv-
ing in rabies-endemic areas, and none
of the travellers were working with
animals. Many travellers also did not
fall into other categories that are tradi-
tionally considered “high-risk” (eg,
prolonged travel, travelling to rural
areas, participating in outdoor adven-
tures, working with animals, or
planned activities involving animals).
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4 Postexposure prophylaxis in 65 travellers who were injured by animals while 
overseas in rabies-endemic countries
Details of postexposure prophylaxis No. (%) of travellers
Started postexposure prophylaxis overseas after bite
Yes 40 (62%)
No 25 (38%)
Received rabies immunoglobulin overseas
Yes 9 (14%)
No 54 (83%)
Not required 1 (2%)
Unknown 1 (2%)
Received all doses of postexposure prophylaxis*
Yes 35 (54%)
No 29 (45%)
Unknown 1 (2%)
* Rabies immunoglobulin and vaccines. ◆11/12) · 5/19 December 2011
ResearchThe most common sites for animal
bites were hands and fingers, which
are high-risk areas for rabies transmis-
sion because of rich nerve supplies.
Most travellers were injured while
engaging in common tourist activities.
More than a third did not initiate contact
with animals, which indicates that advis-
ing travellers to avoid animals does not
guarantee that they will not be bitten.
Our study highlights Indonesia (Bali)
and Thailand as particularly high-risk
destinations. Considering the recent
emergence of rabies in Bali since 2008,7
and the disproportionate number of
travellers who were injured while feed-
ing or interacting with monkeys at a
monkey temple or monkey forest, we
recommend that all travellers to Bali
should be warned against these high-
risk activities. Travellers aged between
20 and 29 years are at particular risk, and
special consideration should be given to
this age group when recommending
rabies pre-exposure vaccination.
There are potential sources of bias in
the study, because it only included trav-
ellers who presented to travel clinics on
return to Australia, and only clinics in
Queensland and Western Australia.
Potential exposures are also likely to be
underreported, and some travellers
might not seek PEP after injuries. Trav-
ellers who present to travel clinics are
potentially better informed about the
risk of rabies, and more motivated to
seek PEP.
Our findings confirm the difficulties
of obtaining adequate PEP and RIG in
developing countries.5,8-10 As a result,
there were delays in starting PEP, and
only half of our travellers were able to
comply with WHO recommendations.
With the current worldwide shortage of
human RIG,1 difficulties of access are
likely to continue. Delays in starting or
failure to complete timely PEP may
result in vaccine failure and the risk of
fatal rabies infection.11 Pre-exposure
vaccination against rabies will also
reduce the cost of PEP to the health care
system, but additional evidence would
be required to inform a formal cost–
benefit analysis.
Rabies vaccination is safe and effec-
tive, and provides long-term protec-
tion.1 Pre-exposure vaccination using
the intradermal route has been proven
to be safe and effective for immuno-
competent people when performed at a
travel medicine clinic with adequately
trained nurses, and can be completed at
a third of the cost of intramuscular
injections.1,12 However, postvaccination
serological testing is recommended 2–3
weeks after an intradermal course to
confirm immunity,2 and some travellers
will not have sufficient time to complete
this before departure.
Based on our findings, we recom-
mend that all travellers to rabies-
endemic areas should be counselled
about the risk of animal bites, warned
about high-risk behaviours, and given
the option of pre-exposure vaccination.
They should be advised about PEP in
case of exposure, the difficulties of
obtaining PEP in some parts of the
world, and should be allowed to make
an informed decision about whether
pre-exposure vaccination is appropriate
for their circumstances.
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